Technische Universität Dresden

Gesture retrieval and its application to the study of multimodal communication (2023) Parian-Scherb M, Uhrig P, Rossetto L, Dupont S, Schuldt H Journal article Extracting structured information from unstructured histopathology reports using generative pre-trained transformer 4 (GPT-4) (2023) Truhn D, Loeffler CM, Müller-Franzes G, Nebelung S, Hewitt KJ, Brandner S, Bressem KK, et al. Journal article Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia (2023) Eckardt JN, Stasik S, Röllig C, Petzold A, Sauer T, Scholl S, Hochhaus A, et al. Journal article Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock (2023) Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, Blankenberg S, et al. Journal article Poly(benzimidazobenzophenanthroline)-Ladder-Type Two-Dimensional Conjugated Covalent Organic Framework for Fast Proton Storage** (2023) Wang M, Wang G, Naisa C, Fu Y, Gali SM, Paasch S, Wang M, et al. Journal article Unravelling the Molecular Structure and Confining Environment of an Organometallic Catalyst Heterogenized within Amorphous Porous Polymers** (2023) Jabbour R, Ashling CW, Robinson TC, Khan AH, Wisser D, Berruyer P, Ghosh AC, et al. Journal article Direct Laser Interference Patterning of Zirconia Using Infra-Red Picosecond Pulsed Laser: Effect of Laser Processing Parameters on the Surface Topography and Microstructure (2023) Henriques B, Fabris D, Voisiat B, Boccaccini AR, Lasagni AF Journal article In-Situ Computed Tomography - Analysis of a Single-Lap Shear Test with Composite-Metal Pin Joints (2023) Köhler D, Popp J, Kupfer R, Troschitz J, Drummer D, Gude M Conference contribution Past, Present, and Future of Human Chemical Communication Research (2023) Loos H, Schaal B, Pause BM, Smeets MA, Ferdenzi C, Roberts SC, de Groot J, et al. Journal article Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial (2023) Weller J, Schäfer N, Schaub C, Tzaridis T, Zeyen T, Schneider M, Potthoff AL, et al. Journal article